Anixa Biosciences, Inc. (ANIX) vs Outlook Therapeutics, Inc. (OTLK)
A side-by-side comparison of Anixa Biosciences, Inc. and Outlook Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIX
Anixa Biosciences, Inc.
$3.08HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
OTLK
Outlook Therapeutics, Inc.
$0.57HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — ANIX vs OTLK
growth of $100 · dividends reinvested · last 10yANIX -39.3% (-4.9%/yr)OTLK -99.9% (-50.4%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
ANIX OTLK
ANIX vs OTLK: by the numbers
- •OTLK is the larger company ($107M vs $105M market cap).
- •Both run net losses; ANIX's is the smaller (0.00% vs -4416.22% net margin).
Metrics side by side
Valuation
| Metric | ANIX | OTLK |
|---|---|---|
| P/B ratio | 7.24 | N/A |
Profitability
| Metric | ANIX | OTLK |
|---|---|---|
| Gross margin | 0.00% | 46.49% |
| Operating margin | 0.00% | -4744.25% |
| Net margin | 0.00% | -4416.22% |
| ROE | -72.02% | N/A |
| ROIC | -82.35% | -352.19% |
Growth (annualized)
| Metric | ANIX | OTLK |
|---|---|---|
| Total return CAGR (5Y) | -8.26% | -57.40% |
Frequently asked
- How have ANIX and OTLK total returns compared?
- Over the past 10 years, ANIX delivered -4.65% and OTLK delivered -50.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.